Both are options to discuss when depression has not improved enough with antidepressants. TMS uses magnetic pulses; Spravato is an esketamine nasal spray taken under medical supervision. The right choice depends on your treatment history, health, response, and ability to attend visits—not simply which sounds faster.
Transcranial magnetic stimulation (TMS) uses a coil placed against your scalp to deliver magnetic pulses to brain areas involved in mood regulation. It is non-invasive: no surgery, injections, or anesthesia are needed. TMS itself is not a medication, but that does not mean you should stop your current prescriptions.
Spravato is a prescription nasal spray containing esketamine. You take the spray yourself under direct clinical supervision at Psychvisit’s REMS-certified clinic. REMS is a safety program that requires supervised treatment and monitoring. Spravato is not a take-home treatment.
TMS usually involves weekday sessions over several weeks, with treatment sessions around 20–40 minutes depending on the protocol. Spravato usually starts twice weekly for four weeks, then may move to weekly or every-two-week visits based on your response. Each Spravato dose is followed by at least two hours of monitoring; allow extra time for check-in and discharge. Your team will confirm your individual schedule before you start.
TMS benefits generally build over a course of treatment; some people notice improvement after a few weeks. Spravato may improve symptoms within hours to days for some people, but an early response does not guarantee lasting relief. Neither treatment works for everyone, and ongoing follow-up matters for both.
Neither treatment is side-effect-free. TMS can cause scalp discomfort or headaches, and seizures are a rare but serious risk. It does not require sedation. Spravato can cause sleepiness, dizziness, a feeling of disconnection (dissociation), blood pressure increases, and breathing problems; it also carries abuse and misuse risks. Clinical staff monitor you after dosing and decide when you can leave. Arrange a ride home after Spravato and follow the clinic’s driving instructions.
Your clinician reviews your diagnosis, previous antidepressant trials, current medicines, medical history, and safety considerations. For Spravato, the practice’s treatment page describes documenting at least two unsuccessful antidepressant trials for treatment-resistant depression. Clinical suitability and insurance approval are separate decisions; requirements vary by plan. A consultation is needed before either treatment can be recommended.
Psychvisit’s TMS and Spravato pages describe coverage through many major insurance plans. Coverage is not automatic: network status, treatment criteria, prior authorization, copays, and deductibles may affect your costs. Ask the team to verify your specific benefits and explain expected costs before treatment begins. An insurance check is not a guarantee of payment.
There is no single best option for everyone. Consider how frequent shorter TMS visits compare with longer, supervised Spravato visits and transportation needs. Your clinician can help weigh those practical differences alongside your symptoms, prior treatment response, and safety. Do not stop or change medication on your own.